Journal of Ophthalmic Inflammation and Infection

Table 8 Percentage of patients with no pain at each study visit (ITT)

From: Phase II placebo-controlled study of nepafenac ophthalmic suspension 0.1% for postoperative inflammation and ocular pain associated with cataract surgery in Japanese patients

Treatment	All (N)	Day 1		Day 3		Day 7		Day 14
Treatment	All (N)	N	%	N	%	N	%	N	%
Nepafenac group	106	103	97.2	104	98.1	103	97.2	103	97.2
Placebo group	105	91	86.7	88	83.8	85	81.0	91	86.7
P value			0.0051		0.0003		0.0002		0.0051

Test = Chi-square

Back to article page